Use of Indapamide SR in elderly patients in general practice: Results of a prospective study of 3.034 elderly multimorbid patients

European Journal of Geriatrics

Volumn 3, Issue 4, 2001, Pages 196-200

  Fusgen I ^a   Schutz D ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Concomitant diseases; Diuretic; Indapamide SR; Long term antihypertensive treatment; Tolerability

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE; METOPROLOL; NIFEDIPINE;

ADULT; AGED; AGING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; DIURETIC THERAPY; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED DISEASE; FEMALE; GENERAL PRACTICE; GERIATRIC PATIENT; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PROSPECTIVE STUDY; PRURITUS; SUSTAINED RELEASE PREPARATION; TACHYCARDIA; TREATMENT OUTCOME; VERTIGO; VISUAL DISORDER;

EID: 0035193497     PISSN: 14391147     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Low-dose antihypertensive therapy with 1.5 mg sustained-release Indapamide: Results of randomized double-blind controlled studies
2. Pharmakotherapie der hypertonie in der ärztlichen Praxis
3. Effects of indapamide in rats with pressure overload left ventricular hypertrophy
4. A comparison of Indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: A randomized double-blind controlled study
5. Regression of left ventricular hypertrophy in hypertensive patients treated with Indapamide SR 1.5 mg versus enalapril 20 mg: The LIVE-study
6. Low-dose antihypertensive therapy with Indapamide 1.5 mg SR coated tablets, pooled data from two European multicenter randomized double-blind studies in 690 patients
7. World Health Organization - International society of hypertension guidelines for the management of hypertension
8. Twenty-four hour antihypertensive efficacy of indapamide, 1.5 mg sustained release: Results of two randomized double-blind controlled studies
9. Publikation von anwendungsbeobachtungen
10. Optimierung der blutdruckeinstellung: Erfahrungen mit Indapamid SR